BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33590949)

  • 21. p53 modulation of the DNA damage response.
    Helton ES; Chen X
    J Cell Biochem; 2007 Mar; 100(4):883-96. PubMed ID: 17031865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA damage strength modulates a bimodal switch of p53 dynamics for cell-fate control.
    Chen X; Chen J; Gan S; Guan H; Zhou Y; Ouyang Q; Shi J
    BMC Biol; 2013 Jun; 11():73. PubMed ID: 23800173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of p53-mediated apoptosis as a crucial anti-tumor response to genomic instability: lessons from mouse models.
    Attardi LD
    Mutat Res; 2005 Jan; 569(1-2):145-57. PubMed ID: 15603759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A single mutant, A276S of p53, turns the switch to apoptosis.
    Reaz S; Mossalam M; Okal A; Lim CS
    Mol Pharm; 2013 Apr; 10(4):1350-9. PubMed ID: 23402381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Context is key: Understanding the regulation, functional control, and activities of the p53 tumour suppressor.
    Moxley AH; Reisman D
    Cell Biochem Funct; 2021 Mar; 39(2):235-247. PubMed ID: 32996618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 and cyclin G cooperate in mediating genome stability in somatic cells of Drosophila.
    Bayer FE; Zimmermann M; Fischer P; Gromoll C; Preiss A; Nagel AC
    Sci Rep; 2017 Dec; 7(1):17890. PubMed ID: 29263364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of Gene Expression Trajectories Initiated from ErbB Receptor Activation Highlights the Dynamics of Divergent Promoter Usage.
    Carbajo D; Magi S; Itoh M; Kawaji H; Lassmann T; Arner E; Forrest AR; Carninci P; Hayashizaki Y; Daub CO; ; Okada-Hatakeyama M; Mar JC
    PLoS One; 2015; 10(12):e0144176. PubMed ID: 26658111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coordination between cell proliferation and apoptosis after DNA damage in Drosophila.
    Ruiz-Losada M; González R; Peropadre A; Gil-Gálvez A; Tena JJ; Baonza A; Estella C
    Cell Death Differ; 2022 Apr; 29(4):832-845. PubMed ID: 34824391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor suppressor protein p53 recruits human Sin3B/HDAC1 complex for down-regulation of its target promoters in response to genotoxic stress.
    Bansal N; Kadamb R; Mittal S; Vig L; Sharma R; Dwarakanath BS; Saluja D
    PLoS One; 2011; 6(10):e26156. PubMed ID: 22028823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Another fork in the road--life or death decisions by the tumour suppressor p53.
    Carvajal LA; Manfredi JJ
    EMBO Rep; 2013 May; 14(5):414-21. PubMed ID: 23588418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P53 promoter selection: choosing between life and death.
    Das S; Boswell SA; Aaronson SA; Lee SW
    Cell Cycle; 2008 Jan; 7(2):154-7. PubMed ID: 18212532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA binding cooperativity of p53 modulates the decision between cell-cycle arrest and apoptosis.
    Schlereth K; Beinoraviciute-Kellner R; Zeitlinger MK; Bretz AC; Sauer M; Charles JP; Vogiatzi F; Leich E; Samans B; Eilers M; Kisker C; Rosenwald A; Stiewe T
    Mol Cell; 2010 May; 38(3):356-68. PubMed ID: 20471942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites.
    Qian H; Wang T; Naumovski L; Lopez CD; Brachmann RK
    Oncogene; 2002 Nov; 21(51):7901-11. PubMed ID: 12420228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Putting the brakes on p53-driven apoptosis.
    Höpker K; Hagmann H; Khurshid S; Chen S; Schermer B; Benzing T; Reinhardt HC
    Cell Cycle; 2012 Nov; 11(22):4122-8. PubMed ID: 22983126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of cell fate by c-Abl activation in the response to DNA damage.
    Kharbanda S; Yuan ZM; Weichselbaum R; Kufe D
    Oncogene; 1998 Dec; 17(25):3309-18. PubMed ID: 9916993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TIGAR, a p53-inducible regulator of glycolysis and apoptosis.
    Bensaad K; Tsuruta A; Selak MA; Vidal MN; Nakano K; Bartrons R; Gottlieb E; Vousden KH
    Cell; 2006 Jul; 126(1):107-20. PubMed ID: 16839880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-phase dynamics of p53 in the DNA damage response.
    Zhang XP; Liu F; Wang W
    Proc Natl Acad Sci U S A; 2011 May; 108(22):8990-5. PubMed ID: 21576488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 dynamics orchestrates with binding affinity to target genes for cell fate decision.
    Wu M; Ye H; Tang Z; Shao C; Lu G; Chen B; Yang Y; Wang G; Hao H
    Cell Death Dis; 2017 Oct; 8(10):e3130. PubMed ID: 29048401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate.
    Knights CD; Catania J; Di Giovanni S; Muratoglu S; Perez R; Swartzbeck A; Quong AA; Zhang X; Beerman T; Pestell RG; Avantaggiati ML
    J Cell Biol; 2006 May; 173(4):533-44. PubMed ID: 16717128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Che-1 modulates the decision between cell cycle arrest and apoptosis by its binding to p53.
    Desantis A; Bruno T; Catena V; De Nicola F; Goeman F; Iezzi S; Sorino C; Gentileschi MP; Germoni S; Monteleone V; Pellegrino M; Kann M; De Meo PD; Pallocca M; Höpker K; Moretti F; Mattei E; Reinhardt HC; Floridi A; Passananti C; Benzing T; Blandino G; Fanciulli M
    Cell Death Dis; 2015 May; 6(5):e1764. PubMed ID: 25996291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.